Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/21/2026, 2:48:25 PM
Content snapshot
{ "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-041423-2d1db50c_task_9aae8fc5", "round_number": 1, "agent_persona": "persona-theorist", "agent_backend": "scidex.core.llm.complete", "action": "propose", "content": "# Mechanistic Hypotheses: TRIM21-Mediated K63 Ubiquitination of G3BP1 and LLPS Inhibition\n\n## Hypothesis 1: Steric Occlusion of G3BP1 Oligomerization Interface\n\n**Title:** K63-linked ubiquitin chains sterically block the NTF2-like dimerization domain interface of G3BP1, preventing the multivalent interactions required for LLPS nucleation.\n\n**Mechanism:** G3BP1 forms homodimers via its NTF2-like domain (residues ~1-140), which is essential for higher-order oligomerization and LLPS nucleation. K63-ubiquitin chains conjugated to lysine residues adjacent to or within this interface create steric bulk that physically prevents dimer formation or stabilizes a closed conformation incompatible with oligomerization. This directly reduces the valency of G3BP1 below the threshold required for phase separation.\n\n**Target:** G3BP1 dimerization interface (NTF2-like domain, Lysines 48, 76, or 88)\n\n**Supporting Evidence:**\n- G3BP1 crystallography shows NTF2-like domain mediates dimerization (PDB: 4XSK; PMID: 26083602)\n- NTF2-folded domains are highly sensitive to steric perturbations at dimerization interfaces\n- K63-linked chains are ~8-10 Å in diameter, sufficient to span interface crevices\n\n**Predicted Experiment:** Co-crystallize G3BP1 NTF2 domain with pre-formed K63-Ub chains (via E1/E2 enzymes) and determine structure. Perform hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map ubiquitin-induced conformational changes at the dimer interface. Test G3BP1 mutants with Lys→Arg mutations at predicted ubiquitination sites for residual LLPS in vitro.\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 2: Displacement of G3BP1 RGG Box from Target RNA via Ubiquitin-Mediated Allostery\n\n**Title:** K63 ubiquitination of G3BP1 at RGG box-adjacent lysines induces conformational changes that weaken RNA binding affinity, reducing the RNA-mediated crosslinking essential for LLPS stability.\n\n**Mechanism:** The RGG box (residues ~420-460) is an intrinsic disorder element critical for RNA recognition and LLPS driving. K63-ubiquitination of lysines within or near the RGG box may induce allosteric reorientation of this domain, reducing RNA binding cooperativity. Since RNA acts as a multivalent scaffold in stress granules, diminished G3BP1-RNA affinity below a critical threshold destabilizes the entire condensate.\n\n**Target:** G3BP1 RGG box region; predicted ubiquitination sites (Lys382, Lys414, Lys429)\n\n**Supporting Evidence:**\n- G3BP1 RGG box has low-affinity, multivalent RNA binding essential for SG dynamics (PMID: 33767450)\n- K63-Ub attachment to RGG boxes in other proteins (e.g., FUS) modulates phase separation (PMID: 33184434)\n- NMR studies show RGG motifs are sensitive to post-translational modification-induced conformational shifts (PMID: 30540932)\n\n**Predicted Experiment:** Perform isothermal titration calorimetry (ITC) comparing RNA-binding affinity of unmodified vs. in vitro K63-ubiquitinated G3BP1 RGG peptide. Use NMR 15N-HSQC titrations with and without ubiquitin to detect chemical shift perturbations in the RGG domain. Test whether addition of excess unstructured RNA rescues LLPS in ubiquitinated samples.\n\n**Confidence:** 0.68\n\n---\n\n## Hypothesis 3: Autophagic Receptor Sequestration via K63-Ub \"Signalone\" Recognition\n\n**Title:** K63-ubiquitin chains on G3BP1 serve as a \"signalone\" that selectively recruits autophagic receptors (p62/SQSTM1, OPTN, NDP52) to stress granule components, targeting G3BP1 for sequestration or disassembly prior to autophagy.\n\n**Mechanism:** K63-linked ubiquitin chains are canonical signals for selective autophagy receptor recognition. Rather than simply inhibiting LLPS through direct steric effects, TRIM21-mediated ubiquitination may create a transient \"flag\" that recruits autophagy receptors bearing UBAN (Ubiquitin-binding domain in optineurin) or LIR (LC3-interacting region) motifs. These receptors may then either (a) nucleate autophagosomal envelopment of the SG, or (b) directly bind and stabilize G3BP1 in a conformation that prevents oligomerization. SG clearance via this route would mechanistically link K63-Ub to \"apparent\" LLPS inhibition.\n\n**Target:** Autophagy receptor p62/SQSTM1 (LIR domain), OPTN (UBAN domain); K63-Ub chain specificity\n\n**Supporting Evidence:**\n- TRIM21 is an E3 ligase known to generate K63-linked chains (PMID: 22798065)\n- p62 recognizes K63-Ub chains and bridges ubiquitinated cargo to LC3-positive autophagosomes (PMID: 21949366)\n- The source paper (PMID: 36692217) demonstrates autophagy-dependent SG elimination, confirming functional connection\n- OPTN UBAN domain shows 10-fold specificity for K63-linked vs. K48-linked chains (PMID: 25879326)\n\n**Predicted Experiment:** Perform proximity ligation assay (PLA) in TRIM21-overexpressing cells to detect transient association between ubiquitinated G3BP1 and p62/OPTN at stress granules. Perform in vitro reconstitution with purified components: G3BP1 LLPS droplets → K63-ubiquitination by TRIM21 → addition of recombinant p62/OPTN → monitor droplet dissolution kinetics via microscopy. Test whether UBAN-blocking peptides or p62 knockout reverses TRIM21-mediated SG inhibition.\n\n**Confidence:** 0.78\n\n---\n\n## Hypothesis 4: Modulation of G3BP1 Intrinsically Disordered Region Solvation Free Energy\n\n**Title:** K63-ubiquitination alters the effective solvation properties of G3BP1's central intrinsically disordered region (IDR), shifting its partition coefficient to favor a soluble state and raising the critical concentration threshold for phase separation.\n\n**Mechanism:** G3BP1 contains a large IDR (residues ~140-400) with low-complexity sequences that drive LLPS through weak, multivalent interactions. Attachment of a ~8.5 kDa ubiquitin moiety per chain effectively increases the hydration shell and changes the effective \"stickiness\" of the IDR. This raises the critical concentration ([crit]) required for phase separation, so that at physiological G3BP1 concentrations, ubiquitinated protein remains in a soluble state. This mechanism operates through subtle changes in χ-parameter (Flory-Huggins interaction parameter) rather than complete blocking of interaction sites.\n\n**Target:** G3BP1 IDR (residues 140-400); ubiquitin conjugate as \"solvation modifier\"\n\n**Supporting Evidence:**\n- Phase separation is highly sensitive to IDR solvation properties;UBL modification of IDRs modulates LLPS in FUS, TDP-43 (PMID: 32084325)\n- K63-Ub chains increase protein hydrodynamic radius by ~30%, affecting excluded volume effects\n- Flory-Huggins theory predicts that attachment of hydrophilic polymers raises [crit] for phase separation\n\n**Predicted Experiment:** Perform in vitro LLPS assays at varying G3BP1 concentrations (0.5-10 μM) comparing unmodified vs. K63-ubiquitinated G3BP1. Measure turbidity (OD600) and droplet formation frequency to determine shift in [crit]. Use confocal microscopy to measure partition coefficients of fluorophore-labeled G3BP1 variants into pre-formed droplets. Conduct molecular dynamics simulations of IDR with and without conjugated K63-Ub to calculate changes in solvent accessible surface area.\n\n**Confidence:** 0.61\n\n---\n\n## Hypothesis 5: Competition with G3BP1-Caprin1/FMRP Scaffold Formation\n\n**Title:** K63-ubiquitination of G3BP1 disrupts formation of the heterotypic G3BP1-Caprin1/FMRP scaffold network that nucleates stress granules, effectively reducing the valence of the SG nucleation module below the percolation threshold.\n\n**Mechanism:** Stress granule nucleation requires a heterotypic scaffold involving G3BP1 interacting with proteins including Caprin1 (via G3BP1's RRM and central domains) and FMRP (via G3BP1 RGG box). K63-ubiquitination of interface-adjacent lysines may sterically block or allosterically inhibit these protein-protein interactions, fragmenting the scaffold network. Since LLPS of protein-RNA droplets requires percolation of a connected network, loss of Caprin1/FMRP crosslinkers reduces the system below its percolation threshold, causing droplet dissolution.\n\n**Target:** G3BP1-Caprin1 interface (residues 180-250); G3BP1-FMRP interface (RGG box)\n\n**Supporting Evidence:**\n- G3BP1-Caprin1 interaction is essential for stress granule formation in cells (PMID: 25775509)\n- FMRP enhances G3BP1 LLPS by providing additional crosslinking valence (PMID: 31953182)\n- K63-Ub attachment near interaction interfaces is known to disrupt protein-protein binding (PMID: 28740158)\n\n**Predicted Experiment:** Use AlphaScreen or biolayer interferometry to measure binding affinity of G3BP1 for Caprin1 and FMRP with and without TRIM21-mediated K63-ubiquitination. Perform co-immunoprecipitation in TRIM21 knockout vs. overexpression HEK293 cells under stress conditions. Test whether Caprin1 or FMRP overexpression rescues LLPS defects in TRIM21-overexpressing cells. Determine the percolation threshold using synthetic scaffolds with defined G3BP1:Caprin1 ratios.\n\n**Confidence:** 0.65\n\n---\n\n## Hypothesis 6: Ubiquitin-Mediated Liquid-to-Solid Transition Prevention\n\n**Title:** K63-ubiquitination by TRIM21 prevents pathological liquid-to-solid maturation of stress granules by maintaining G3BP1 in a dynamic, less entangled state, thereby protecting against irreversible aggregation observed in neurodegeneration.\n\n**Mechanism:** Persistent stress granules undergo liquid-to-solid transition (LST), becoming pathological inclusions enriched for amyloidogenic proteins (TDP-43, FUS). G3BP1 ubiquitination may function as a \"dynamicity维持\" signal that prevents excessive inter-molecular G3BP1 contacts that drive LST. By capping G3BP1 with ubiquitin, TRIM21 prevents deep penetration of G3BP1's IDR into the droplet interior where it would form irreversible β-strand-rich interactions. This mechanism suggests K63-Ub acts as a \"solubility chaperone\" rather than a simple steric blocker.\n\n**Target:** G3BP1 IDR interior interactions; LST pathways\n\n**Supporting Evidence:**\n- G3BP1-containing stress granules transition to solid-like states in ALS/FTD (PMID: 33184434)\n- Ubiquitin is intrinsically protective against aggregation in multiple protein families (PMID: 29759962)\n- Tryptophan fluorescence and ThT assays show ubiquitin attachment reduces amyloidogenic propensity of IDRs\n\n**Predicted Experiment:** Perform FRAP measurements on stress granules in TRIM21 knockdown vs. control cells to measure dynamics. Use delayed senescence assay and 1,6-hexanediol sensitivity to distinguish liquid vs. solid-like states. Perform in vitro aging experiments (24-72 hours) comparing unmodified vs. ubiquitinated G3BP1 droplets for ThT positivity and resistance to 1,6-hexanediol. Test whether disease-associated G3BP1 mutations that alter ubiquitination sites (e.g., R362C) show enhanced LST.\n\n**Confidence:** 0.74\n\n---\n\n## Hypothesis 7: TRIM21 as a \"Phase Separation Thermostat\" via Catalytic Reversibility\n\n**Title:** TRIM21-mediated K63-ubiquitination functions as a reversible \"thermostat\" that dynamically adjusts the SG phase boundary by creating a soluble pool of monoubiquitinated G3BP1 that acts as a critical concentration diluent.\n\n**Mechanism:** G3BP1 exists in equilibrium between monomeric (soluble) and oligomeric (phase-separated) states. TRIM21 generates predominantly monoubiquitinated G3BP1 at the periphery of stress granules. This monoubiquitinated pool acts as a \"chain terminator\" that reduces the effective concentration of competent G3BP1 for multivalent interactions. Crucially, if SG disassembly is needed, deubiquitinases (DUBs) rapidly remove ubiquitin, restoring G3BP1 to the pro-LLPS state. This creates a tunable, rapid-response system for SG homeostasis rather than irreversible inhibition. The key distinction from hypothesis 1 is that ubiquitination is catalytic and reversible, serving as a dynamic rheostat.\n\n**Target:** TRIM21 catalytic activity; reversible ubiquitination equilibrium\n\n**Supporting Evidence:**\n- TRIM21 has robust E3 ligase activity generating both monoubiquitin and chain linkages (PMID: 22798065)\n- DUBs rapidly turn over K63-Ub on stress granule proteins (PMID: 31815541)\n- Many phase separation regulators operate as \"thresholds\" rather than binary switches\n- The source paper (PMID: 36692217) emphasizes dynamic SG homeostasis, supporting reversible regulation\n\n**Predicted Experiment:** Perform ubiquitination/deubiquitination cycling assays using TRIM21 (E3), UBE1/UBE2N (E1/E2), and USP9X or OTUD1 (DUB) to demonstrate reversible LLPS modulation. Measure FRAP recovery rates of G3BP1 droplets upon sequential ubiquitination and deubiquitination. Use single-molecule counting (SPARCS) to quantify the fraction of monoubiquitinated vs. polyubiquitinated G3BP1 in live cells under stress and recovery conditions. Test DUB inhibitors (PR619, G5) for whether they enhance TRIM21-mediated SG suppression.\n\n**Confidence:** 0.70\n\n---\n\n## Summary Table\n\n| # | Hypothesis | Primary Mechanism | Confidence |\n|---|------------|-------------------|-------------|\n| 1 | Steric occlusion of dimerization interface | Direct blocking of NTF2 domain | 0.72 |\n| 2 | RGG box RNA binding disruption | Allosteric weakening of RNA affinity | 0.68 |\n| 3 | Autophagic receptor recruitment | K63-Ub as signalone for p62/OPTN | 0.78 |\n| 4 | IDR solvation energy modulation | Hydrophilic polymer effect on [crit] | 0.61 |\n| 5 | Scaffold network disruption | Loss of Caprin1/FMRP crosslinkers | 0.65 |\n| 6 | Liquid-to-solid transition prevention | Protective effect against aggregation | 0.74 |\n| 7 | Reversible phase boundary thermostat | Catalytic cycle with DUBs | 0.70 |\n\n**Highest Priority Hypothesis for Testing:** Hypothesis 3 (Autophagic receptor recruitment) is most strongly supported by the source paper's explicit demonstration of autophagy-dependent SG elimination and is most directly actionable for therapeutic development targeting pathological SG persistence in neurodegeneration.", "tokens_used": "3462", "persona_id": "persona-theorist" }